Screening out irrelevant cell-based models of disease | Nature Reviews Drug Discovery
Therapeutic targeting of the complement system | Nature Reviews Drug Discovery
PAASP publication in Nature Reviews Drug Discovery: Improving target assessment in biomedical research - the GOT-IT recommendations - paasp network
Optical biosensors in drug discovery | Nature Reviews Drug Discovery
Volume 13 | Nature Reviews Drug Discovery
Nature Reviews - Nature Reviews Drug Discovery: Invasive fungal infections are a major medical concern, particularly in immunocompromised patients. In this Review, Perfect discusses the antifungal pipeline, including advances in the currently
Volume 19 | Nature Reviews Drug Discovery
The future of drug development: advancing clinical trial design | Nature Reviews Drug Discovery
Volume 19 Issue 6, June 2020
Nature Reviews Drug Discovery (@NatRevDrugDisc) / Twitter
Nature Reviews Drug Discovery | CountryOfPapers
Molecular imaging in drug development | Nature Reviews Drug Discovery
Article series : Nature Reviews Drug Discovery
Volume 18 Issue 6, June 2019
Target deconvolution strategies in drug discovery | Nature Reviews Drug Discovery
The druggable genome | Nature Reviews Drug Discovery
THe LOnG pROCeSS OF DRuG DISCOVeRy FROm ORIGInAL IDeA (?) THROuGH THe... | Download Scientific Diagram
Volume 14 | Nature Reviews Drug Discovery
Volume 15 | Nature Reviews Drug Discovery
Can the pharmaceutical industry reduce attrition rates? | Nature Reviews Drug Discovery
Volume 3 | Nature Reviews Drug Discovery
Phase II and Phase III attrition rates 2011–2012 | Nature Reviews Drug Discovery
Predicting in vivo drug interactions from in vitro drug discovery data | Nature Reviews Drug Discovery
Volume 10 | Nature Reviews Drug Discovery
Volume 21 Issue 12, December 2022
Volume 21 Issue 9, September 2022
